Naringin inhibits cisplatin resistance of ovarian cancer cells by inhibiting autophagy mediated by the TGF-2/smad2 pathway.
Briefly

This website offers information but does not provide medical advice for diagnosing or treating diseases. It advises consulting a licensed healthcare professional before starting any treatment regimen.
Disclaimer: The content on this site is for educational purposes and does not intend to diagnose, treat, cure, or prevent any disease. Consult a licensed healthcare professional before starting any treatment.
Read at Greenmedinfo
[
|
]